Compare · LUCY vs WRBY
LUCY vs WRBY
Side-by-side comparison of Innovative Eyewear Inc. (LUCY) and Warby Parker Inc. (WRBY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LUCY and WRBY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- WRBY is the larger of the two at $3.39B, about 609.5x LUCY ($5.6M).
- Over the past year, LUCY is down 62.0% and WRBY is up 16.7% - WRBY leads by 78.7 points.
- WRBY has been more active in the news (10 items in the past 4 weeks vs 6 for LUCY).
- WRBY has more recent analyst coverage (25 ratings vs 0 for LUCY).
PerformanceLUCY-61.97%WRBY+14.41%
2025-07-17+0.00%2026-07-16
- Company
- Innovative Eyewear Inc.
- Warby Parker Inc.
- Price
- $0.81-5.26%
- $27.32-1.10%
- Market cap
- $5.6M
- $3.39B
- 1M return
- -8.47%
- +8.79%
- 1Y return
- -61.97%
- +16.70%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- 2021
- News (4w)
- 6
- 10
- Recent ratings
- 0
- 25
WRBY
Warby Parker Inc.
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Latest LUCY
- Innovative Eyewear, Inc. Announces New Claude AI Integration for All Lucyd Smart Eyewear
- Innovative Eyewear Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Innovative Eyewear, Inc. Announces Exercise of Warrants For Approximately $3.0 Million in Gross Proceeds
- Innovative Eyewear, Inc. Announces 345-Store Rollout with FYihealth Group
- Innovative Eyewear Q2 2026 Net Sales Up 71% Year-Over-Year in Twelfth Consecutive Quarter of Growth
- Innovative Eyewear, Inc. Partners with Encore Optical Laboratory to Provide New Lens Technologies for Smart Eyewear
- Innovative Eyewear Inc. Reports Q1 2026 Unaudited Financial Results
- SEC Form 10-Q filed by Innovative Eyewear Inc.
- Innovative Eyewear, Inc. Announces Real-Time AI Translated Calls for the Lucyd App
- Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.
Latest WRBY
- Warby Parker to Announce Second Quarter 2026 Financial Results on August 6, 2026
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 9,200 shares and sold $275,908 worth of shares (9,200 units at $29.99) as part of a pre-agreed trading plan (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 54,347 shares and sold $1,621,714 worth of shares (54,347 units at $29.84) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Warby Parker Inc.
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 189,320 shares and sold $6,445,120 worth of shares (217,667 units at $29.61) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 213,746 shares and sold $7,191,541 worth of shares (242,221 units at $29.69) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Director Raider Jeffrey Jacob sold $668,700 worth of shares (22,500 units at $29.72) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 435,201 units (SEC Form 4)
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 36,300 shares and sold $1,090,452 worth of shares (36,300 units at $30.04) as part of a pre-agreed trading plan (SEC Form 4)
- BofA Securities initiated coverage on Warby Parker with a new price target
- SEC Form 4 filed by Co-Chief Executive Officer Blumenthal Neil Harris